GPhA lauds FDA approval of Omnitrope

The Evolving Landscape of Insulin Delivery in Diabetes Management

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

Brian Nowosielski;Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.

Killian Meara

Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease

The new presentation of Shingrix will allow for easier administration.

Killian Meara;Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP;Hailey Choi, PharmD, BCACP, CDCES

July 15th 2025

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.

Bristol Myers Squibb, Pfizer to Sell Eliquis Direct to Patients

Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.

Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy

The 2 corporations formed the Bristol Myers Squibb-Pfizer Alliance and will be offering discounted Eliquis to eligible patients starting September 8, 2025.

Related Content

The Evolving Landscape of Insulin Delivery in Diabetes Management

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

Brian Nowosielski;Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.

Killian Meara

Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic Disease

The new presentation of Shingrix will allow for easier administration.

Killian Meara;Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP;Hailey Choi, PharmD, BCACP, CDCES

July 15th 2025

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.

Bristol Myers Squibb, Pfizer to Sell Eliquis Direct to Patients

Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.